Review



fluorogenic cathepsin v substrate  (BPS Bioscience)


Bioz Manufacturer Symbol BPS Bioscience manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 94

    Structured Review

    BPS Bioscience fluorogenic cathepsin v substrate
    Fluorogenic Cathepsin V Substrate, supplied by BPS Bioscience, used in various techniques. Bioz Stars score: 94/100, based on 3 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/fluorogenic cathepsin v substrate/product/BPS Bioscience
    Average 94 stars, based on 3 article reviews
    fluorogenic cathepsin v substrate - by Bioz Stars, 2026-02
    94/100 stars

    Images



    Similar Products

    94
    BPS Bioscience fluorogenic cathepsin v substrate
    Fluorogenic Cathepsin V Substrate, supplied by BPS Bioscience, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/fluorogenic cathepsin v substrate/product/BPS Bioscience
    Average 94 stars, based on 1 article reviews
    fluorogenic cathepsin v substrate - by Bioz Stars, 2026-02
    94/100 stars
      Buy from Supplier

    90
    Peptide Institute fluorogenic substrate of cathepsin e mocac-gly-lys-pro-ile-ile-phe-phe-arg-leu-lys(dnp)-d-arg-nh 2 code 3200-v
    Selection of cathepsin E (CE)-inhibitory peptides . (a) An MMV plate plan adopted for the selection of CE-inhibitory peptides. First, magnetic beads were added to MMV1 and transferred to MMV2. MMV2 was changed with a cell-free transcription/translation solution. Independently, MMV3 was subjected to amplification of DNA (PCR reaction) and the products were transferred to MMV2. After transcription and translation reactions in MMV2, generated proteins were treated with restriction protease Xa, releasing peptides from the protein bound on the magnetic bead. After removal of magnetic beads, the supernatant was transferred to MMV5 which contains cathepsin E and its <t>fluorogenic</t> substrate. After incubation, the fluorescent product was monitored with a fluoroimager. The symbol 'arrow with a spiral' means that the preceding MMV is layered upside down as a donor MMV to the following one (recipient MMV). (b) Selection of CE-inhibitory peptides. In this case, dark wells contain CE-inhibitory peptides which block the CE enzyme reaction (generation of fluorescent products) and result in no production of fluorescent products. The arrows in inset indicate the inhibitory peptide-containing wells.
    Fluorogenic Substrate Of Cathepsin E Mocac Gly Lys Pro Ile Ile Phe Phe Arg Leu Lys(Dnp) D Arg Nh 2 Code 3200 V, supplied by Peptide Institute, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/fluorogenic substrate of cathepsin e mocac-gly-lys-pro-ile-ile-phe-phe-arg-leu-lys(dnp)-d-arg-nh 2 code 3200-v/product/Peptide Institute
    Average 90 stars, based on 1 article reviews
    fluorogenic substrate of cathepsin e mocac-gly-lys-pro-ile-ile-phe-phe-arg-leu-lys(dnp)-d-arg-nh 2 code 3200-v - by Bioz Stars, 2026-02
    90/100 stars
      Buy from Supplier

    Image Search Results


    Selection of cathepsin E (CE)-inhibitory peptides . (a) An MMV plate plan adopted for the selection of CE-inhibitory peptides. First, magnetic beads were added to MMV1 and transferred to MMV2. MMV2 was changed with a cell-free transcription/translation solution. Independently, MMV3 was subjected to amplification of DNA (PCR reaction) and the products were transferred to MMV2. After transcription and translation reactions in MMV2, generated proteins were treated with restriction protease Xa, releasing peptides from the protein bound on the magnetic bead. After removal of magnetic beads, the supernatant was transferred to MMV5 which contains cathepsin E and its fluorogenic substrate. After incubation, the fluorescent product was monitored with a fluoroimager. The symbol 'arrow with a spiral' means that the preceding MMV is layered upside down as a donor MMV to the following one (recipient MMV). (b) Selection of CE-inhibitory peptides. In this case, dark wells contain CE-inhibitory peptides which block the CE enzyme reaction (generation of fluorescent products) and result in no production of fluorescent products. The arrows in inset indicate the inhibitory peptide-containing wells.

    Journal: BMC Biotechnology

    Article Title: Novel concept microarray enabling PCR and multistep reactions through pipette-free aperture-to-aperture parallel transfer

    doi: 10.1186/1472-6750-10-71

    Figure Lengend Snippet: Selection of cathepsin E (CE)-inhibitory peptides . (a) An MMV plate plan adopted for the selection of CE-inhibitory peptides. First, magnetic beads were added to MMV1 and transferred to MMV2. MMV2 was changed with a cell-free transcription/translation solution. Independently, MMV3 was subjected to amplification of DNA (PCR reaction) and the products were transferred to MMV2. After transcription and translation reactions in MMV2, generated proteins were treated with restriction protease Xa, releasing peptides from the protein bound on the magnetic bead. After removal of magnetic beads, the supernatant was transferred to MMV5 which contains cathepsin E and its fluorogenic substrate. After incubation, the fluorescent product was monitored with a fluoroimager. The symbol 'arrow with a spiral' means that the preceding MMV is layered upside down as a donor MMV to the following one (recipient MMV). (b) Selection of CE-inhibitory peptides. In this case, dark wells contain CE-inhibitory peptides which block the CE enzyme reaction (generation of fluorescent products) and result in no production of fluorescent products. The arrows in inset indicate the inhibitory peptide-containing wells.

    Article Snippet: A newly made MMV was treated to equilibrate with a permeation solution (50 mM sodium acetate, 0.1 M NaCl, pH 4.5) containing 5 μM fluorogenic substrate of cathepsin E (CE) MOCAc-Gly-Lys-Pro-Ile-Ile-Phe-Phe-Arg-Leu-Lys(DnP)-D-Arg-NH 2 (Code 3200-V, Peptide Institute, Inc., Osaka), and was half-filled with a CE reaction solution (permeation solution containing 5 μM substrate and 5 pmol CE additively).

    Techniques: Selection, Magnetic Beads, Amplification, Generated, Incubation, Blocking Assay